Lawrence J. Hineline

Companies

• Intra-Cellular Therapies, Inc.Chief financial officer Sep 9, 2013 to Mar 11, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ICIntra-Cellular Therapies, Inc.0 shares²Mar 11, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 11, 2024Sold 64 shares at $67.12 of Intra-Cellular Therapies, Inc.²
• Mar 11, 2024Sold 4,475 shares at $66.47 of Intra-Cellular Therapies, Inc.²
• Mar 11, 2024Sold 29 shares at $67.32 of Intra-Cellular Therapies, Inc.²
• Mar 11, 2024Sold 1,100 shares at $66.54 of Intra-Cellular Therapies, Inc.²
• Mar 11, 2024Sold 4,453 shares at $65.28 of Intra-Cellular Therapies, Inc.²
• Mar 10, 2024Exercised options 4,539 shares at $56.73 of Intra-Cellular Therapies, Inc.²
• Mar 10, 2024Exercised options 5,582 shares of Intra-Cellular Therapies, Inc.²
• Mar 7, 2024Sold 6,618 shares at $66.93 of Intra-Cellular Therapies, Inc.²
• Mar 7, 2024Sold 6,514 shares at $66.26 of Intra-Cellular Therapies, Inc.²
• Mar 6, 2024Exercised options 13,132 shares of Intra-Cellular Therapies, Inc.³
• Feb 26, 2024Sold 600 shares at $69.81 of Intra-Cellular Therapies, Inc.⁴
• Feb 26, 2024Sold 5,282 shares at $69.47 of Intra-Cellular Therapies, Inc.⁴
• Feb 26, 2024Exercised options 5,882 shares at $36.89 of Intra-Cellular Therapies, Inc.⁴
• Feb 26, 2024Sold 288 shares at $70.15 of Intra-Cellular Therapies, Inc.⁴
• Feb 26, 2024Sold 6,867 shares at $69.38 of Intra-Cellular Therapies, Inc.⁴
• Feb 26, 2024Sold 300 shares at $68.33 of Intra-Cellular Therapies, Inc.⁴
• Feb 23, 2024Exercised options 7,455 shares of Intra-Cellular Therapies, Inc.⁴
• Feb 2, 2024Sold 185 shares at $67.35 of Intra-Cellular Therapies, Inc.⁵
• Feb 2, 2024Sold 10,998 shares at $66.61 of Intra-Cellular Therapies, Inc.⁵
• Feb 1, 2024Granted 11,183 shares of Intra-Cellular Therapies, Inc.⁵
• Jun 14, 2023Sold 3,592 shares at $65.01 of Intra-Cellular Therapies, Inc.⁶
• Jun 14, 2023Sold 44,035 shares at $64.37 of Intra-Cellular Therapies, Inc.⁶
• Jun 14, 2023Sold 34,227 shares at $63.35 of Intra-Cellular Therapies, Inc.⁶
• Jun 14, 2023Exercised options 4,538 shares at $56.73 of Intra-Cellular Therapies, Inc.⁶
• Jun 14, 2023Exercised options 11,762 shares at $36.89 of Intra-Cellular Therapies, Inc.⁶